Akshay Vaishnaw, SVP, R&D at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 43,750 shares at $65.00 ($2.8M) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Open-market sale of $2.8M ALNY by SVP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.00 | 11,000 | $715K | 25.1% |
| 2 | $65.00 | 32,750 | $2.1M | 74.9% |
| Total | $65.00 avg | 43,750 | $2.8M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |